Key Highlights- Mission Bio expands into single-cell multi-omics with the launch of its new proprietary technology platform. - The Tapestri Platform is the first and only to enable key insights to drive the development of more impactful cancer therapies. Mission Bio, Inc., a South San Francisco, CA-based pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced its expansion into single-cell multi-omics. The company’s proprietary technology, the Tapestri
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Aetion, IBM Watson Health Co-Develop Solution for Conducting Regulatory-Grade RWE Analysis
- IBM Watson Health and Aetion will combine the Aetion Evidence Platform with IBM MarketScan data to provide a turn-key solution for conducting regulatory-grade RWE analysis. - The partnership will satisfy mid-market companies’ demand to streamline the drug R&D process and will allow RWE to play a much greater role in support of companies’ drug portfolios. RWE can enable researchers to supplement clinical trials by optimizing the development of treatments, determining new indications for
Read More
3 Myths About Robotic Process Automation in Healthcare, Debunked
Patients’ wellbeing should be the central focus of healthcare. Unfortunately, this isn’t always the case. Studies show that doctors spend almost half their time on data entry and more than half of their workdays managing records instead of caring for patients. Add this lost time to the fact that healthcare in the United States is already understaffed – averaging 2.5 healthcare practitioners to every 1,000 patients – and it’s easy to see that something’s got to give to bring
Read More
Healx Nabs $56M to Expand AI-Driven Drug Discovery Platform for Rare Diseases
- UK startup Healx lands $56M, led by Atomico to build an AI-driven clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism.
- Healx’s Rare Treatment Accelerator program is a new initiative launched in close partnership with patient communities to identify clinic-ready treatments for rare diseases within 24 months.
Healx, a Cambridge, England-based AI-powered and patient-inspired technology company specializing in
Read More
McKesson, Aetion Partner on Real-World Evidence (RWE) in Cancer Research
- Aetion and McKesson announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research. - Relationship pairs Aetion Evidence Platform and McKesson’s robust oncology data sets to accelerate regulatory-grade oncology studiesAetion and McKesson, today announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research to benefit patients, regulators, the biopharma industry, and payers. The partnership will
Read More
Informa Pharma Intelligence Launches Solution to Accelerate Clinical Trial Timelines
- Citeline Engage will deliver real-world data and customized engagement opportunities to help customers optimize site selection and increase trial efficiencies to accelerate clinical trial timelines.- Informa’s new product is uniquely capable of addressing these pain points by utilizing trial and investigator intelligence available through Informa’s Citeline with a verified audience of healthcare professionals through Skipta to help CROs and sponsors expedite patient enrollment, drive
Read More
Life Image, Graticule Partner to Help Biopharma Accelerate Drug Development
- Life Image partners with Graticule to help biopharma realize the full potential of advanced data in real-world evidence programs.
- Partnership combines Life Image’s global medical evidence network specializing in imaging data with Graticule’s deep expertise applying advanced data to high-value use cases.
Life Image, the world’s largest medical evidence network for clinical and imaging data has announced a new partnership with Graticule to help life sciences companies accelerate drug
Read More
BiomeSense Nabs $2M to Expand Daily Gut Microbiome Tracking Platform
- BiomeSense raises $2M in seed funding to expand its biosensor and analytics platform for daily gut microbiome tracking. - The company is working on completing its prototype biosensor and data modeling platform in preparation for the first clinical trials, scheduled for 2020.- The trials will investigate cancer progression, immunotherapy response, surgical recovery and athletic performance.BiomeSense, a Chicago, IL-based microbiome startup developing a novel biosensor and analytics platform for
Read More
Novartis to Establish AI Innovation Lab, Taps Microsoft As Strategic AI & Data Science Partner
- Novartis to establish the Novaris AI innovation lab and has formed a strategic partnership with Microsoft as its AI and data science partner.
- AI Innovation lab will leverage Novartis datasets with Microsoft’s advanced AI solutions, the lab will aim to create new AI models and applications to transform medicine.
- Novartis and Microsoft's strategic alliance will focus on the two core objectives of AI Empowerment and AI Exploration.
Novartis announced the formation of
Read More
Ambry Genetics Launches Paired RNA and DNA Testing for Hereditary Cancer
- Ambry launches a new genetic test, +RNAinsight that changes the standard for “clinical grade” testing, with higher accuracy.- +RNAinsight enables clinicians – for the first time ever – to conduct both DNA and RNA genetic testing at the same time.- Ambry is the first and only lab to offer paired RNA and DNA genetic testing for hereditary cancer.Ambry Genetics (Ambry), a clinical genetic testing company, announced today the launch of +RNAinsight, a major advancement in genetic testing.
Read More
